South Africa vs Zambia: Antiretroviral therapy coverage for PMTCT
South Africa
98.0%
in 2024
Zambia
98.0%
in 2024
South Africa rank
9th
Zambia rank
9th
Antiretroviral therapy coverage for PMTCT over time
- South Africa
- Zambia
How they compare
South Africa currently reports 98.0% against 98.0% in Zambia, a difference of 0.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Zambia ahead.
South Africa ranks 9th and Zambia ranks 9th of 84 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Africa | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.3% | 27.6% | 0.7% | South Africa |
| 2010s | 96.3% | 80.8% | 15.5% | South Africa |
| 2020s | 96.8% | 94.6% | 2.2% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, South Africa or Zambia?
- South Africa, at 98.0% against 98.0% in Zambia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between South Africa and Zambia?
- 0.0%, with South Africa ahead.
- How many years of comparable data are there for South Africa and Zambia?
- 25 years are reported by both, from 2000 to 2024.
- How do South Africa and Zambia rank globally for antiretroviral therapy coverage for pmtct?
- South Africa ranks 9th and Zambia ranks 9th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).